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RESEARCH ARTICLE Open Access
Long-term results of the iBP elbow
prosthesis: beware of destructive
metallosis!
Daniëlle Meijering1*, Alexander L. Boerboom1, Fred Breukelman2, Denise Eygendaal3,4, Sjoerd K. Bulstra1 and
Martin Stevens1
Abstract
Background: The aim of this study was to review the long-term results of the instrumented Bone Preserving (iBP)
elbow prosthesis.
Methods: Thirty-one patients (10 M, 21F, 28-77 year) were retrospectively evaluated using the Oxford Elbow Score
(OES), Disabilities of Arm, Shoulder and Hand Outcome Measure (DASH), Mayo Elbow Performance (MEPS), physical
examination and standard radiographs. Kaplan-Meier survival analysis was used.
Results: Thirty-seven primary iBPs have been placed in 31 patients between 2000 and 2007. Six patients (8
prostheses) had died, 10 elbows had been revised and three patients (4 prostheses) were lost to follow-up.
Fourteen patients (15 prostheses) were available for follow-up. The main indication for surgery was rheumatoid
arthritis. Mean follow-up was 11 years (8–15). Kaplan-Meier survival analysis showed a survival of 81% at 10 years
after surgery. Main reason for revision was particle disease and loosening due to instability and malalignment.
Eleven of 14 patients were satisfied, although radiographs showed radiolucencies in 11 patients.
Conclusion: The iBP elbow prosthesis gives a survival rate of 81% 10 years after surgery with a progressive decline
beyond 10 years. However, many patients have radiolucencies. Discrepancy between clinical signs and radiological
results warrants structural follow-up, to assure quality of bone stock in case revision surgery is indicated.
The study was reviewed and approved by the Medical Ethical Committee of University Medical Center Groningen
(METc2016/038).
Level of evidence: Level IV, Case series.
Keywords: iBP, Elbow prosthesis, Unlinked elbow prosthesis, arthroplasty, Long-term follow-up
Background
Joint destruction due to inflammatory arthritis is still the
main reason for a total elbow arthroplasty (TEA),
although nowadays posttraumatic osteoarthritis is a
more common indication for a replacement [1, 2]. As
the prevalence of TEA is low compared to knee and hip
arthroplasties, reports with long-term follow-up are
rather scarce.
Over the last 40 years there have been many improve-
ments in the design of total elbow prostheses. In general,
three types of prostheses are available: unlinked devices,
linked devices and convertible devices, which can be
used as either a linked or an unlinked system. The
instrumented Bone Preserving (iBP) (Biomet, Warsaw,
IN, USA) elbow prosthesis is an unlinked, ulnohumeral
prosthesis, designed by Pooley. The iBP elbow prosthesis
is a modification of the Kudo type 5, developed to
preserve more bone stock (Fig. 1) [3]. A study with a
mean follow-up of 49 months by Kleinlugtenbelt et al.
[4] showed a discrepancy between clinical outcome and
radiological signs. Patients scoring good-to-excellent on
the Mayo Elbow Performance Score (MEPS) did show
radiolucencies around their ulnar component, while
patients with a poor MEPS score did not. As a result of
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this discrepancy, progressive radiolucency can occur
without any clinical symptoms, which results in bone
loss, hampering the results of revision surgery. In a study
with a mean follow-up of 7.5 years, Dalemans et al. [5]
reported a drop in survival 6 years after surgery due to
instability, infection and metallosis, but they did not see
loosening of the components in their patients. The aim
of this study was to assess the long-term results of the
iBP elbow prosthesis.
Methods
Between April 2000 and June 2009 37 primary iBP total
elbow arthroplasties in 31 patients have been performed
at University Medical Center of Groningen by 4 different
orthopedic surgeons. All 31 patients (37 elbows) with a
primary iBP were included in this study. Nineteen
elbows were left and 18 were right elbows. Mean age of
the patients was 55 at the time of surgery. Ten patients
were male, 21 female. Indications for surgery were pain-
ful destruction of the elbow joint due to rheumatoid
arthritis in 23 patients (28 elbows), posttraumatic osteo-
arthritis in 3 patients and haemophilic arthropathy in 5
patients (6 elbows). Patients’ characteristics are shown in
Table 1.
The study was reviewed and approved by the Medical
Ethical Committee of UMCG (METc2016/038). None of
the surgeons was involved in the design of the implant.
Surgical technique
In all cases a posterior approach was used with a triceps
split technique as described by Pooley [3, 6]. The ulnar
nerve was released and protected during the procedure.
Release of the collateral ligaments were performed in
case of contractures. The radial head was excised in all
cases. The humerus and ulna were prepared with preser-
vation of as much bone as possible according to the
philosophy of this prosthesis. All humeral components
were inserted without cement, except for 6 elbow pros-
theses in which poor bone quality urged to the use of
cement. All ulnar components were cemented.
Post-operatively the elbow was protected by a removable
cast for 4 weeks, avoiding active extension. Thereafter, the
elbow was mobilized without brace and active triceps train-
ing was allowed. Patients were advised to limit weight
bearing up to 1 kg repetitively and to 5 kg incidentally.
Outcome measures
To assess pain, elbow function and social-psychological
status, the Oxford Elbow Score (OES) [7] was used. Dis-
abilities of Arm, Shoulder and Hand Outcome Measure
(DASH) [8] was used to assess upper-limb function. The
Mayo Elbow Performance Score (MEPS) [9] was used to
assess pain, range of motion and stability. Health-related
quality of life was determined by using the EQ. 5D-3 L
VAS score [10]. Pain at rest and during activities was
scored from 0 (no pain) to 10 (severe pain) using visual
analogue scales (VAS). Patients were also asked whether
they were satisfied with their elbow function. By means
of physical examination we determined the active range
of motion (ROM). The integrity of the ulnar nerve was
assessed using careful clinical examination. The stability
of the medial and lateral collateral ligaments was scored
as grade 0, no instability; grade 1, moderate instability
(< 10°) and grade 2 severe instability (> 10°). All patients
had standard anteroposterior (AP) and lateral radio-
graphs of the elbow. Loosening of the implants was
classified using the system described by Wagener et al.
[11] (Fig. 2). Radiographs were also assessed of disloca-
tion of the prosthesis, subluxation, periprosthetic frac-
tures and signs of metallosis.
Statistical analysis
SPSS statistical software (version 24.0, IBM SPSS, Chicago)
was used. Descriptive statistics were used to describe
patients’ characteristics, clinical outcomes and scores on
the questionnaires. Kaplan-Meier survival analysis was
performed with revision as an end point. Kruskal-Wallis
Test for independent samples was used to analyze differ-
ences in indication for surgery.
Results
The mean follow-up of this study is 11 (8–15) years. At
follow-up 6 patients (8 elbows) had died. Ten elbow pros-
theses in 10 patients had already been revised, leaving 19
primary prostheses in 17 patients in situ. Unfortunately,
three patients (4 elbows) could not participate in our
Fig. 1 iBP uncemented (left) and cemented (right) ulnar and
humeral components
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Table 1 Patient characteristics
Age range (years): 1 = 20–29, 2 = 30–39, 3 = 40–49, 4 = 50–59, 5 = 60–69, 6 = 70–79,
HA haemophilic arthropathy, RA rheumatoid arthritis, PTA post-traumatic arthritis, C cemented, H hybrid (humeral component cementless), AL aseptic loosening,
INF infection, INST instability, MET metallosis, ULN ulnaropathy, DIS = dislocation, † = died
Fig. 2 Classification of radiological analysis as described by Wagener et al. In each zone we looked for the presence of radiolucencies
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follow-up, as they were physically unable to come to the
hospital. However, they did not have complaints of their
elbow. Fourteen patients with 15 primary iBP elbow pros-
theses were available for clinical assessment (Fig. 3).
Survival
The Kaplan-Meier survival analysis (Fig. 4) showed
survival rates of 88 and 81% respectively at 5 and 10
years after surgery. All 37 primary iBP’s were included in
this analysis. Furthermore, a progressive decline in
survival is visible beyond 10 years. Ten out of 37 iBP
elbow prostheses had been revised. The reasons for early
revision were infection in one patient, aseptic loosening
in two patients and instability in two patients, which
occurred in the first 4 years after surgery. The reason for
late revision (after 9 years) was loosening with severe
polyethylene wear and as a consequence metallosis in 5
patients (Figs. 5,6). Arrows show radiolucency (orange)
around the prosthesis and severe pseudotumor (blue),
indicating metallosis.
Clinical assessment
Overall, most patients were satisfied with their iBP
elbow prosthesis. Only 2 out of 14 patients were not
satisfied with the result. One patient was not satisfied,
because of ulnar neuropathy and loss of function.
Another patient was no longer satisfied because of loos-
ening of the ulnar component that had led to loss of
function. No revision arthroplasty was planned though
because of severe comorbidities. One patient was indif-
ferent, which left 11 patients (12 elbows) being satisfied
with their iBP elbow prosthesis.
Mean MEPS score was 80 points (45–100) indicating a
fair-to-good result. Lower scores indicated pain in most
cases. Mean DASH score was 44 points (17–70) and mean
OES 34 points (14–48). This score usually indicates mild-
to-moderate elbow complaints. The underlying disease,
rheumatoid arthritis, mainly influenced both scores, as illus-
trated by the health-related quality of life score: 6 (4–8). As-
sessment of pain on a 0–10 point scale scored a mean of 2
(0–7), indicating low pain levels.
Mean ROM was 90° (40°-125°), mean flexion 125°
(70°-145°), mean extension deficit 35° (5°-70°). Mean
pronation 70° (40°-95°), mean supination 75° (40°-95°).
Seven out of 15 elbows were unstable. Two of them
were grossly unstable and 5 were moderately unstable,
although this was not clinically relevant in terms of
dislocation. Three of 14 patients had signs of persistent
ulnar neuropathy. There were no significant differences
in clinical outcomes and survival between indication for
surgery.
Radiological assessment
At the assessment, one out of 15 cases showed loosening
of the ulnar component with a fracture in zone 3. Eleven
out of 15 cases showed radiolucent lines, especially in
zones 1 and 3 of the ulna. Three cases showed incongru-
ity and another 3 cases showed signs of metallosis and
pseudotumor (Table 2). Looking back at the already
revised cases, 5 of 10 cases (all late revisions) had severe
radiolucencies (especially zones 1 and 3 of the ulna) and
signs of metallosis, which was confirmed at revision
surgery.
All together in 15 of 25 cases (revisions and survivals)
the radiographs indicated bone loss due to particle
disease with PE wear and metallosis as to be expected.
The case shown in Fig. 5 demonstrated radiolucencies
and pseudotumor, suggestive for metallosis. Painful loos-
ening 10 years after primary surgery led to a revision in
which severe bone loss was encountered.
Fig. 3 Flow diagram of iBP elbow prostheses
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Discussion
The iBP elbow prosthesis is an unlinked prosthesis. The
stability of the joint is provided by the soft tissues, there-
fore the risk of dislocation is higher than in a linked-type
prosthesis [12, 13]. The theoretical advantage of this de-
sign is the lower risk of loosening, because of minimal
stress on the bone-implant interface [5].
Our study shows survival rates for the iBP elbow pros-
thesis of 88 and 81% respectively at 5 and 10 years post-
operatively with a progressive decline in survival beyond
10 years. Eleven of 14 patients were satisfied with their
elbow as reflected in the scores of the questionnaires. In
our study the main reason for revision was loosening
with polyethylene wear and metallosis (50%), which is
higher compared to the results of Dalemans et al.(33%),
but they only had a follow-up of 7.5 years with their
series of the iBP elbow prosthesis [5, 12, 13]. In their
series with the Kudo 5, an unlinked prosthesis with a
mean follow-up of 14.5 years, the main reason for revi-
sion was loosening and metallosis as well (61%). The
unlinked prostheses were originally developed to render
less loosening than linked prostheses, but Voloshin et al.
showed in their systematic review no significant
Fig. 4 Kaplan-Meier survival analysis curve with revision for any reasons as an endpoint
Fig. 5 Radiological signs of PE wear and metallosis. Orange arrows
showing radiolucencies, blue arrows showing pseudotumor Fig. 6 Revision arthroplasty by humeral osteotomy: severe metallosis
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difference in clinically relevant loosening between linked
and unlinked elbow prostheses [12].
Over the last years improvements in the quality of PE
have been made. A recent study by Popoola et al. [14]
showed that vitamin E blended and crosslinked poly-
ethylene gives lower in vitro wear compared to conven-
tional gamma-irradiated polyethylene in two types of
linked, semiconstrained total elbow prostheses. Probably
motion in combination with the thin polyethylene in the
design of the iBP prosthesis eventually leads to wear,
metallosis and loosening.
When revising the iBP we had to revise the ulnar com-
ponent in 3 of 10 cases.
In 6 of 10 cases persistent instability due to debridement
of soft tissue and insufficiency of the collateral ligaments,
required revision to a linked-type total elbow prosthesis.
In one case a complete iBP revision was performed.
The relatively short survival and the described wear
problems and loosening of the ulnar component in com-
bination with the difficulties experienced in revision of
an even well-fixed humeral stem have made us decide to
stop using this prosthesis.
Another well-known complication after TEA is ulnar
neuropathy [15–18]. In our study 3 patients (20%) had
some form of permanent ulnaropathy, despite the ulnar
nerve was mobilized and protected during surgery. The
reported outcomes on neuropathy after elbow prosthetic
joint placement are conflicting. Tanaka et al. did not find
ulnaropathy after release of the nerve [18]. On the other
hand, not mobilizing the ulnar nerve as shown by Klein-
lugtenbelt et al. resulted in 6% ulnaropathy [4], by Brink-
man et al. a high rate of 20% ulnar neuropathy was
found [15]. Postoperative ulnar neuropathy rates appear
to vary, so we recommend further research to determine
whether mobilization of the ulnar nerve is preferred.
Mean arc of motion in our study was 90°, with a mean
flexion of 125° and a mean extension deficit of 35°. Mean
pronation was 70° and mean supination 75°. Morrey et
al. [19] described that the functional arc of motion
required for activities in daily life was 120/30 for flexion/
extension and 50/50° for pronation/supination. Five out
of 14 patients had a range of motion inferior to this
standard. Most of the patients were nonetheless satisfied
with their elbow function.
Table 2 Radiological analysis
AP anteroposterior, Lat Lateral. Numbers indicate zone of radiolucency as described in Fig. 2
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Few studies have been conducted to determine the
long-term outcome of the iBP elbow prosthesis. One
study by Kleinlugtenbelt et al. [4] showed a discrepancy
between clinical evaluation and radiological signs at
short-term follow-up, with a mean follow-up of 4 years.
Our study showed this discrepancy too.
Loosening of the ulnar component was seen in 11 pa-
tients, although 8 of them did not have any complaints
of their elbow. In 9 of these 11 patients radiolucencies
around the humeral component were seen. Seven pa-
tients had some degree of elbow instability at physical
examination without dislocation; 3 of them did show
radiological signs of subluxation.
Our current ‘care as usual’ does not routinely include
medium or long term follow-up. The outcome of this
study has changed our policy and we routinely do a
structural follow-up. Patient related outcome measures
only will not be sufficient to assess the integrity of these
implants. Following this study, another three prostheses
have been revised. All three of them with severe poly-
ethylene wear and metallosis.
Limitations
We were only able to examine a small number of
patients. Our study had a retrospective design, which
entailed an important loss of patients. The strength of
this study is the length of follow-up.
Conclusion
We warrant a structural follow-up for all iBP implants,
because of the discrepancy between clinical signs and
symptoms and radiological loosening, metallosis and
consequent progressive bone loss.
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